Provectus Biopharmaceuticals Operating Margin Growth & History (PVCT)

Provectus Biopharmaceuticals's operating margin was −1,575.32% for fiscal 2025.

View full Provectus Biopharmaceuticals company overview

Provectus Biopharmaceuticals annual operating margin history

Provectus Biopharmaceuticals annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−1,575.32%−840.90 pp
20242024-12-31−734.42%−214.21 pp
20232023-12-31−520.21%−173.62 pp
20222022-12-31−346.59%—

Provectus Biopharmaceuticals operating margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Provectus Biopharmaceuticals's operating margin decreased from −346.59% to −1,575.32%, a change of −1228.72 percentage points. The latest reported quarter, Q2 2025, shows −3,132.79%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Provectus Biopharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about PVCT yet. Start the conversation.

Write the first post